Alarming increase in ciprofloxacin- and penicillin-resistant Neisseria gonorrhoeae isolates in New Delhi, India

Sex Transm Dis. 2003 Jun;30(6):523-5. doi: 10.1097/00007435-200306000-00010.

Abstract

Background: Resistance of ciprofloxacin has been reported in several regions of the world, including India. In India, ciprofloxacin is still being used as single-dose treatment for gonorrhea.

Goal: The aim of the study was to determine the antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients with acute gonococcal urethritis in New Delhi.

Study design: By means of disc diffusion, we determined the susceptibility profiles of N gonorrhoeae isolates, determined the MICs of ciprofloxacin, penicillin, and ceftriaxone, and compared our data with previous findings.

Results: On the basis of MIC values, 35.3% and 52.9% of strains were found to be resistant and less sensitive, respectively, to penicillin; 67.3% and 28.2% strains were observed to be resistant and less sensitive, respectively, to ciprofloxacin. Only one isolate (5.9%) was found to be less sensitive to ceftriaxone.

Conclusion: The significant increase in ciprofloxacin resistance in the current study indicates that resistance has developed under selective antibiotic pressure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • Anti-Infective Agents / therapeutic use
  • Ceftriaxone / pharmacology
  • Ceftriaxone / therapeutic use
  • Ciprofloxacin / pharmacology*
  • Ciprofloxacin / therapeutic use
  • Drug Resistance, Microbial
  • Gonorrhea / drug therapy
  • Gonorrhea / microbiology*
  • Humans
  • India
  • Male
  • Microbial Sensitivity Tests
  • Neisseria gonorrhoeae / drug effects*
  • Neisseria gonorrhoeae / isolation & purification
  • Penicillin Resistance
  • Penicillins / pharmacology*
  • Penicillins / therapeutic use

Substances

  • Anti-Infective Agents
  • Penicillins
  • Ciprofloxacin
  • Ceftriaxone